|
|
Mr. Svennilson has twenty-five years of experience in
corporate finance, investment banking, and venture capital. He was the founder
and a partner of Three Crowns Capital, a leading backer of a new generation of
U.S. biotechnology companies. He helped found companies like Rosetta, PTC,
Tercica and Somalogic and over the past sixteen years has helped finance and
develop biotech companies such as Tularik, Sunesis, Chemocentryx, Infinity,
AVEO, Rinat and FivePrime. He is currently a Board Director of NGM
Biopharmaceuticals, Aragon Pharmaceuticals and PTC Therapeutics and has served
on the Board of Directors of several other biotechnology companies including
Rosetta, Somalogic and ChemoCentryx. Prior to Three Crowns Capital he was the
Associate Managing Director in charge of European Investment Banking Origination
at Nomura Securities in London. Mr. Svennilson is currently a Trustee for The
Institute for Advanced Study in Princeton, New Jersey.
TCG Board Representation: Aragon Pharmaceuticals, NGM Biopharmaceuticals, PTC Therapeutics
|